FATE THERAPEUTICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Xu Yuan | — | Award / Grant | 4,744 | — | — | 4,744 | Aug 3, 2021 |
| Wolchko J Scott | President and CEO | Option Exercise | 30,000 | $2.73 | $81,900 | 423,793 | Jul 23, 2021 |
| TAHL CINDY | General Counsel and Secretary | Option Exercise | 15,383 | $6.55 | $100,759 | 163,582 | Jul 1, 2021 |
| Plavsic Mark | Chief Technical Officer | Award / Grant | 38,000 | — | — | 38,000 | Jun 14, 2021 |
| Valamehr Bahram | Chief Development Officer | Option Exercise | 16,156 | $2.90 | $46,852 | 111,896 | Jun 14, 2021 |
| HERSHBERG ROBERT | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| COUGHLIN TIMOTHY | — | Award / Grant | 2,681 | — | — | 59,071 | Jun 2, 2021 |
| RASTETTER WILLIAM H | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| EPSTEIN ROBERT S | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| Jooss Karin | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| Agarwal Shefali | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| MENDLEIN JOHN | — | Award / Grant | 2,681 | — | — | 159,455 | Jun 2, 2021 |
| Redmile Group, LLC | — | Award / Grant | 2,681 | — | — | 12,959,903 | Jun 2, 2021 |
| Lee Michael Stewart | — | Award / Grant | 2,681 | — | — | 2,681 | Jun 2, 2021 |
| Wolchko J Scott | President and CEO | Sale | 20,000 | $77.16 | $1,543,200 | 393,793 | May 20, 2021 |
| Wolchko J Scott | President and CEO | Option Exercise | 14,846 | $6.62 | $98,281 | 418,639 | Apr 22, 2021 |
| Chu Yu-Waye | Senior VP Clinical Development | Sale | 1,500 | $84.41 | $126,615 | 64,800 | Apr 16, 2021 |
| TAHL CINDY | See Remarks | Sale | 5,299 | $86.76 | $459,741 | 108,448 | Apr 1, 2021 |
| Valamehr Bahram | Chief Development Officer | Sale | 8,404 | $92.64 | $778,547 | 99,963 | Mar 15, 2021 |
| Shoemaker Daniel D | Chief Scientific Officer | Sale | 2,480 | $83.46 | $206,981 | 79,448 | Mar 8, 2021 |
| Wolchko J Scott | President and CEO | Sale | 8,602 | $102.26 | $879,641 | 399,340 | Feb 18, 2021 |
| Wolchko J Scott | President and CEO | Sale | 6,520 | $99.35 | $647,762 | 396,868 | Jan 22, 2021 |
| Valamehr Bahram | Chief Development Officer | Award / Grant | 18,013 | — | — | 95,740 | Jan 20, 2021 |
| TAHL CINDY | General Counsel and Secretary | Award / Grant | 18,013 | — | — | 108,048 | Jan 20, 2021 |
| Shoemaker Daniel D | Chief Scientific Officer | Award / Grant | 14,411 | — | — | 98,020 | Jan 20, 2021 |
| Dulac Edward J III | Chief Financial Officer | Award / Grant | 18,013 | — | — | 58,013 | Jan 20, 2021 |
| TAHL CINDY | General Counsel and Secretary | Option Exercise | 35,000 | $2.90 | $101,500 | 125,035 | Jan 19, 2021 |
| Wolchko J Scott | President and CEO | Sale | 2,300 | $109.65 | $252,195 | 350,562 | Jan 8, 2021 |
| Valamehr Bahram | Chief Development Officer | Sale | 1,332 | $111.62 | $148,678 | 79,649 | Jan 8, 2021 |
| TAHL CINDY | General Counsel and Secretary | Sale | 2,451 | $117.15 | $287,135 | 94,312 | Jan 8, 2021 |
| Shoemaker Daniel D | Chief Scientific Officer | Sale | 151 | $114.76 | $17,329 | 86,862 | Jan 8, 2021 |
| Redmile Group, LLC | — | Purchase | 327,485 | $85.50 | $27,999,968 | 12,957,222 | Jan 8, 2021 |
| Wolchko J Scott | President and CEO | Sale | 2,796 | $92.94 | $259,860 | 420,069 | Dec 17, 2020 |
| Valamehr Bahram | Chief Development Officer | Sale | 1,006 | $102.06 | $102,672 | 87,311 | Dec 14, 2020 |
| Shoemaker Daniel D | Chief Scientific Officer | Sale | 5,287 | $51.60 | $272,809 | 107,872 | Nov 16, 2020 |
| Wolchko J Scott | President and CEO | Sale | 9,846 | $51.03 | $502,441 | 419,969 | Nov 12, 2020 |
| TAHL CINDY | General Counsel and Secretary | Option Exercise | 10,000 | $2.90 | $29,000 | 118,800 | Nov 5, 2020 |
| TAHL CINDY | General Counsel and Secretary | Option Exercise | 29,199 | $2.73 | $79,713 | 128,717 | Oct 16, 2020 |
| TAHL CINDY | General Counsel and Secretary | Option Exercise | 35,000 | $2.73 | $95,550 | 134,518 | Oct 1, 2020 |
| Valamehr Bahram | Chief Development Officer | Option Exercise | 21,924 | $2.90 | $63,580 | 112,211 | Sep 14, 2020 |
| Shoemaker Daniel D | Chief Scientific Officer | Sale | 5,713 | $37.12 | $212,067 | 118,091 | Sep 14, 2020 |
| Dulac Edward J III | Chief Financial Officer | Award / Grant | 40,000 | — | — | 40,000 | Aug 17, 2020 |
| Redmile Group, LLC | — | Purchase | 1,412,928 | $28.31 | $39,999,992 | 12,629,737 | Jun 11, 2020 |
| RASTETTER WILLIAM H | — | Option Exercise | 28,461 | $1.37 | $38,992 | 28,461 | Mar 30, 2020 |
| RASTETTER WILLIAM H | — | Gift | 28,461 | — | — | 146,821 | Mar 30, 2020 |
| Valamehr Bahram | Chief Development Officer | Option Exercise | 1,153 | $1.69 | $1,949 | 87,211 | Feb 3, 2020 |
| Wolchko J Scott | President and CEO | Sale | 25,000 | $25.45 | $636,250 | 419,969 | Jan 30, 2020 |
| Wolchko J Scott | President and CEO | Award / Grant | 66,000 | — | — | 419,969 | Jan 8, 2020 |
| Valamehr Bahram | Chief Development Officer | Award / Grant | 25,000 | — | — | 91,758 | Jan 8, 2020 |
| TAHL CINDY | General Counsel and Secretary | Sale | 5,700 | $20.72 | $118,104 | 99,518 | Jan 8, 2020 |